Source: Annual Congress 2005 - Tobacco smoking related health issues



Rating:

Share or cite this content

Citations should be made in the following way:
C. Andrejak, M. Andrejak, P. Aubry, V. Jounieaux (Amiens, France). Adverse reactions to bupropion: fourteen cases reported in a French regional pharmacovigilance center. Impact on smoking withdrawal. Eur Respir J 2005; 26: Suppl. 49, 1022

Member's Comments

No comment yet.

Related content which might interest you: Adverse drug reactions in a pulmonary teaching hospital: Incidence, pattern, seriousness, and preventability Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Management of adverse drug events in TB therapy Source: Eur Respir Mon 2012; 58: 167-193 Year: 2012 Alcohol intake, smoking and illicit drug use in TB patients is under recorded by doctors Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 Adverse effects of MDR-TB treatment with a standardized regimen: A report from Iran Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β2-agonist (LABA) therapy: results from the UK general practice research database (GPRD) Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care Year: 2009 Smoking cessation for free: First long-term outcomes in three Romanian centres Source: International Congress 2015 – Smoking cessation Year: 2015 Adverse events and mortality in the INSPIRE study (investigating new standards for prophylaxis in reduction of exacerbations) Source: Eur Respir J 2007; 30: Suppl. 51, 125s Year: 2007 Adverse anti-tuberculosis drug events and their management Source: Eur Respir Monogr 2018; 82: 205-227 Year: 2018 Putting in Harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for Multidrug-Resistant Tuberculosis Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Efficacy of varenicline among smokers enrolled on a public health tobacco control program (HM-TCP) in the real-life setting Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards Year: 2015 Late-breaking abstract: Long-term efficacy of intensive behavior interventions and free medications for smoking cessation in Brazil Source: Annual Congress 2011 - Smoking cessation science Year: 2011 Changes in the use of anti-asthmatic medication in an international cohort Source: Eur Respir J 2005; 26: 1047-1055 Year: 2005 Prevalence of switching from brand to generic asthma medications Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Evaluation of rate and associated factors with relapse in patients attending smoking cessation programme Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 Occupational exposure and incidence of asthma based on prescription of drugs. Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways Year: 2018 Smoke cessation recommendations and prescriptions in hospitalised medical patients Source: International Congress 2015 – Smoking cessation Year: 2015 Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Adverse pregnancy outcomes and familial confounding in asthmatic women – A population based family design study Source: International Congress 2016 – Predictors of asthma among children and adults Year: 2016 Metrics of salbutamol use as predictors of future adverse outcomes in asthma Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Change in asthma management recommendations is associated with reduction of reliever drugs in the real-world setting: a longitudinal retrospective claims data analysis in Burgenland Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020